tiprankstipranks
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL

Cardiol Therapeutics (CRDL) Ownership - Who Owns Cardiol Therapeutics?

165 Followers

Cardiol Therapeutics (CRDL) Ownership Overview

6.35%0.08%2.35%91.23%
2.35% Other Institutional Investors
91.23% Public Companies and
Individual Investors
The ownership structure of Cardiol Therapeutics (CRDL) stock is a mix of institutional, retail and individual investors. Approximately 2.42% of the company’s stock is owned by Institutional Investors, 6.35% is owned by Insiders and 91.23% is owned by Public Companies and Individual Investors.
The ownership structure of Cardiol Therapeutics (CRDL) stock is a mix of institutional, retail and individual investors. Approximately 2.42% of the company’s stock is owned by Institutional Investors, 6.35% is owned by Insiders and 91.23% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,301,978Institution1.91%2,239,402
1,274,000Insider1.87%2,191,280
1,154,500Insider1.69%1,985,740
760,336Insider1.11%1,307,778
467,290Insider0.68%803,739
239,380Insider0.35%411,734
142,500Insider0.21%245,100
110,000Insider0.16%189,200
90,350Institution0.13%155,402
89,164Insider0.13%153,362

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
52,435Institution0.08%90,188

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Cardiol Therapeutics (CRDL)?
According to the latest TipRanks data, approximately 2.35% of the company's stock is held by institutional investors, 6.35% is held by insiders, and 91.23% is held by retail investors.
    What percentage of Cardiol Therapeutics (CRDL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.35% of Cardiol Therapeutics (CRDL) stock is held by institutional investors.
      What percentage of Cardiol Therapeutics (CRDL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 91.23% of Cardiol Therapeutics (CRDL) stock is held by retail investors.
        Who owns the most shares of Cardiol Therapeutics (CRDL)?
        AdvisorShares owns the most shares of Cardiol Therapeutics (CRDL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis